Language

CAS No. 103877-51-6 | ethyl 7-chloro-8-methyl-4-oxo-1,4-dihydroquinoline-3-carboxylate

CAS No. 103877-51-6 | ethyl 7-chloro-8-methyl-4-oxo-1,4-dihydroquinoline-3-carboxylate

Name: ethyl 7-chloro-8-methyl-4-oxo-1,4-dihydroquinoline-3-carboxylate CAS No. 103877-51-6 MF:C16H16ClNO3 MW:305.76 Purity:95% Package: 5g,25g,200g,500g,1kg Worldwide Delivery

Categories：

Other Life Science Chemicals

Email：sale06@alfachem.cn

Inquiry

Chat Now

Product introduction

Introduction and application of CAS No. 103877-51-6 | ethyl 7-chloro-8-methyl-4-oxo-1,4-dihydroquinoline-3-carboxylate

Synonyms:ethyl7-chloro-1-cyclopropyl-8-methyl-4-oxo-1,4-dihydroquinoline-3-carboxylate;

ethyl7-chloro-1-cyclopropyl-8-methyl-4-oxo-quinoline-3-carboxylate;

7-Chloro-1-cyclopropyl-8-methyl-4-oxo-1,4-dihydro-3-quinolinecarboxylicacidethylester;

7-chloro-8-methyl-4-oxo-1,4-dihydroquinoline-3-carboxylate;

3-Quinolinecarboxylicacid,7-chloro-1-cyclopropyl-1,4-dihydro-8-methyl-4-oxo-,ethylester;

7-Chloro-1-cyclopropyl-8-methyl-4-oxyquinoline-3-carboxylate,ethylester;

Specification:

ITEMS	SPECIFICATION
CAS	103877-51-6
MF	C16H16ClNO3
MW	305.76
Boiling point	448.7±45.0 °C
Density	1.362±0.06 g/cm3
Acidity coefficient	-3.24±0.40
Form	Powder

Overview:

Ozenoxacin is a new fluoroquinolone antimicrobial indicated for the treatment of pustular dermatitis and other skin infections by inhibiting DNA gyrase and topoisomerase IV, as a cream (10g, 1%) Treats bacterial skin infections, including Gram-positive skin and soft tissue infections. At present, the compound has successfully completed Phase III clinical trials for the treatment of pustular dermatitis in adults and children, showing stronger antibacterial activity, good safety and tolerability. The chemical synthesis route of Ozefloxacin is relatively long. In its synthesis process, the following compound is an important intermediate of Ozefloxacin.

Package and transportation :

Package: 5g,25g,200g,500g,1kg